| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
6,548 |
5,735 |
$6.94M |
| J2778 |
Injection, ranibizumab, 0.1 mg |
3,948 |
2,706 |
$2.14M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
14,668 |
11,563 |
$702K |
| 92134 |
|
18,502 |
16,036 |
$283K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
6,977 |
5,865 |
$262K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
2,338 |
2,055 |
$105K |
| 99233 |
Prolong inpt eval add15 m |
693 |
428 |
$51K |
| J9035 |
Injection, bevacizumab, 10 mg |
549 |
503 |
$32K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
449 |
387 |
$13K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
166 |
145 |
$12K |
| 99253 |
|
108 |
106 |
$9K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
29 |
27 |
$2K |
| 92250 |
|
31 |
28 |
$553.60 |